{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:08:07Z","timestamp":1791504487438,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010166","name":"Xiamen City Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073562"],"award-info":[{"award-number":["82073562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["2016-I2M-1\u2013019"],"award-info":[{"award-number":["2016-I2M-1\u2013019"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["2017-I2M-B&R-03"],"award-info":[{"award-number":["2017-I2M-B&R-03"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017529","name":"Major Scientific and Technological Project of Zhejiang Province","doi-asserted-by":"publisher","award":["3502Z20193009"],"award-info":[{"award-number":["3502Z20193009"]}],"id":[{"id":"10.13039\/501100017529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.lanwpc.2021.100196","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T04:20:09Z","timestamp":1626409209000},"page":"100196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study"],"prefix":"10.1016","volume":"13","author":[{"given":"Xingmei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bizhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huirong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lanwpc.2021.100196_bib0001","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lanwpc.2021.100196_bib0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection","volume":"47","author":"de Sanjose","year":"2018","journal-title":"Best practice & research Clinical obstetrics & gynaecology"},{"key":"10.1016\/j.lanwpc.2021.100196_bib0003","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000355964","article-title":"Host responses to infection with human papillomavirus","volume":"45","author":"Stanley","year":"2014","journal-title":"Current problems in dermatology"},{"key":"10.1016\/j.lanwpc.2021.100196_bib0004","unstructured":"WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem. https:\/\/www.who.int\/publications\/i\/item\/9789240014107 (Nov 17, 2020), Accessed 13th Jan 2021."},{"issue":"41","key":"10.1016\/j.lanwpc.2021.100196_bib0005","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.vaccine.2015.08.079","article-title":"The estimated impact of natural immunity on the effectiveness of human papillomavirus vaccination","volume":"33","author":"Matthijsse","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lanwpc.2021.100196_bib0006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/M19-1182","article-title":"Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States","volume":"172","author":"Laprise","year":"2020","journal-title":"Annals of internal medicine"},{"issue":"1","key":"10.1016\/j.lanwpc.2021.100196_bib0007","doi-asserted-by":"crossref","first-page":"e53067","DOI":"10.1371\/journal.pone.0053067","article-title":"HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.lanwpc.2021.100196_bib0008","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/OLQ.0b013e3181e1a2c5","article-title":"Seroprevalence and Correlates of Human Papillomavirus 16\/18 Seropositivity Among Young Women in Costa Rica","volume":"37","author":"Coseo","year":"2010","journal-title":"Sexually Transmitted Diseases"},{"key":"10.1016\/j.lanwpc.2021.100196_bib0009","first-page":"10","article-title":"Determinants of seropositivity among HPV-16\/18 DNA positive young women","author":"Porras","year":"2010","journal-title":"Bmc Infectious Diseases"},{"issue":"4","key":"10.1016\/j.lanwpc.2021.100196_bib0010","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcv.2012.12.004","article-title":"Serum antibodies to human papillomavirus (HPV) pseudovirions correlate with natural infection for 13 genital HPV types","volume":"56","author":"Faust","year":"2013","journal-title":"J Clin Virol"},{"issue":"10","key":"10.1016\/j.lanwpc.2021.100196_bib0011","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/jmv.23664","article-title":"Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women","volume":"85","author":"Tong","year":"2013","journal-title":"Journal of Medical Virology"},{"issue":"03","key":"10.1016\/j.lanwpc.2021.100196_bib0012","first-page":"354","article-title":"Levels of Human Papillomavirus 16\/18 Neutralizing Antibody among 18~45 year-old Women in Liuzhou, Guangxi Province, China: Association with precancerous Lesions of Cervical Cancer","volume":"33","author":"Jun","year":"2017","journal-title":"Chinese Journal of Virology"},{"issue":"6","key":"10.1016\/j.lanwpc.2021.100196_bib0013","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/342972","article-title":"Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles","volume":"186","author":"Ho","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.lanwpc.2021.100196_bib0014","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1055-9965.EPI-03-0166","article-title":"Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica","volume":"13","author":"Viscidi","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.lanwpc.2021.100196_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of quadrivalent HPV 6\/11\/16\/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection","volume":"5","author":"Olsson","year":"2009","journal-title":"Human vaccines"},{"issue":"21","key":"10.1016\/j.lanwpc.2021.100196_bib0016","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/jnci\/djq384","article-title":"Epidemiological Study of Anti-HPV16\/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections","volume":"102","author":"Safaeian","year":"2010","journal-title":"Jnci-J Natl Cancer I"},{"issue":"4","key":"10.1016\/j.lanwpc.2021.100196_bib0017","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/infdis\/jiu139","article-title":"Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16\/18 antibodies: analysis of the control arm of PATRICIA","volume":"210","author":"Castellsague","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.lanwpc.2021.100196_bib0018","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/infdis\/jiy112","article-title":"Risk of HPV-16\/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials","volume":"218","author":"Safaeian","year":"2018","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.lanwpc.2021.100196_bib0019","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/infdis\/jir209","article-title":"A Competitive Serological Assay Shows Naturally Acquired Immunity to Human Papillomavirus Infections in the Guanacaste Natural History Study","volume":"204","author":"Wentzensen","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1016\/j.lanwpc.2021.100196_bib0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jnci\/djz074","article-title":"Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial","volume":"112","author":"Qiao","year":"2020","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1016\/j.lanwpc.2021.100196_bib0021","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4161\/hv.27619","article-title":"Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination","volume":"10","author":"Zhao","year":"2014","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"39","key":"10.1016\/j.lanwpc.2021.100196_bib0022","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1016\/j.vaccine.2020.07.030","article-title":"Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages","volume":"38","author":"Chen","year":"2020","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.lanwpc.2021.100196_bib0023","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/ijc.28896","article-title":"Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial","volume":"135","author":"Zhao","year":"2014","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.lanwpc.2021.100196_bib0024","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/infdis\/jiv753","article-title":"Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis","volume":"213","author":"Beachler","year":"2016","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.lanwpc.2021.100196_bib0025","first-page":"e119","article-title":"Human papillomavirus prevalence and associated factors in women and men in south China: a population-based study","volume":"5","author":"Wei","year":"2016","journal-title":"Emerging microbes & infections"},{"issue":"10","key":"10.1016\/j.lanwpc.2021.100196_bib0026","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1128\/CVI.00197-08","article-title":"Neutralizing antibodies against human papillomavirus types 16, 18, 31, 52, and 58 in serum samples from women in Japan with low-grade cervical intraepithelial neoplasia","volume":"15","author":"Ochi","year":"2008","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"4","key":"10.1016\/j.lanwpc.2021.100196_bib0027","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11427-019-9547-7","article-title":"Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women","volume":"63","author":"Hu","year":"2020","journal-title":"Science China Life sciences"},{"issue":"6","key":"10.1016\/j.lanwpc.2021.100196_bib0028","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1055-9965.EPI-09-1235","article-title":"Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women","volume":"19","author":"Insinga","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266660652100105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266660652100105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:35:33Z","timestamp":1763001333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266660652100105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":28,"alternative-id":["S266660652100105X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100196","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100220","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100196"}}